Search
Carrimycin
go.drugbank.com/drugs/DB16476InvestigationalCategories: Experimental Unapproved Treatments for COVID-19Alphaprodine
go.drugbank.com/drugs/DB13160ExperimentalIllicitCategories: Serotonergic Drugs Shown to Increase Risk of Serotonin SyndromeDiminazene
go.drugbank.com/drugs/DB03608ExperimentalThis compound belongs to the phenylhydrazines. These are compounds containing a phenylhydrazide moiety, which consists of a hydrazide substituent attached to a phenyl group. … Diminazene, also known as Diminazine, 4,4'-(Diazoamino)benzamidine, 4,4'-(1-triazene-1,3-diyl)bis-benzenecarboximidamide, diminazine aceturate, or Diminazene aceturate, is a trypanocidal agent.
Tin protoporphyrin IX
go.drugbank.com/drugs/DB16449InvestigationalSynonyms: TIN, (DIHYDROGEN PROTOPORPHYRIN IX-ATO(2-))-Categories: Experimental Unapproved Treatments for COVID-19, Heterocyclic Compounds with 4 or More RingsMORF-057
go.drugbank.com/drugs/DB23674InvestigationalMORF-057 is under investigation in clinical trial NCT06226883 (A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease).
3'-deoxyguanosine
go.drugbank.com/drugs/DB03609ExperimentalThis compound belongs to the purine nucleosides and analogues. These are compounds comprising a purine base attached to a sugar. This medication targets the protein purine nucleoside phosphorylase.
Heparan-N-sulfatase (human, recombinant)
go.drugbank.com/drugs/DB18483InvestigationalRecombinant human heparan-N-sulfatase (rhHNS) is under investigation for the treatment mucopolysaccharidosis type IIIA.
Fluocortin
go.drugbank.com/drugs/DB13223ExperimentalFluocortin has been studied as a corticosteroid for treatment of dermatitis and eczema Spain [A174817].
Atopaxar
go.drugbank.com/drugs/DB12046InvestigationalAtopaxar has been investigated for the treatment of Coronary Artery Disease and Acute Coronary Syndrome.
AZD-7762
go.drugbank.com/drugs/DB12242InvestigationalAZD7762 has been investigated for the treatment of Cancer, Solid Tumors, and Advanced Solid Malignancies.